Physician profile
Randa Jaafar
NPI 1619126208
$87,424.24
in general payments reported to CMS, 2019-2025
54 companies · $803 in 2025
The $803 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $8,049 · 2021: $15K · 2022: $4,879 · 2023: $2,687 · 2024: $1,621 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,110.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53,166.04 | 2019-2025 | Relistor |
| Boston Scientific Corporation | $21,181.34 | 2019-2024 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Nevro Corp. | $3,773.07 | 2019-2024 | Senza |
| Kowa Pharmaceuticals America, INC. | $1,957.76 | 2022-2023 | Seglentis |
| Merz North America, INC. | $1,102.93 | 2021-2024 | Xeomin |
| Horizon Therapeutics Plc | $673.10 | 2019-2022 | |
| Abbvie INC. | $423.80 | 2021-2024 | |
| Medtronic USA, INC. | $399.41 | 2019-2020 | |
| Stimwave Technologies Incorporated | $368.17 | 2019-2020 | |
| Allergan, INC. | $322.85 | 2019-2022 | |
| Mml US, INC. | $244.30 | 2022-2023 | Reactiv8 |
| Highridge Medical LLC | $235.63 | 2024-2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Becton, Dickinson and Company | $235.00 | 2022 | |
| Merz Pharmaceuticals, LLC | $216.42 | 2024-2025 | Xeomin |
| Amgen INC. | $209.95 | 2019-2020 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $173.92 | 2019-2025 | |
| Terumo Medical Corporation | $162.71 | 2022 | |
| Neuronetics, INC. | $154.11 | 2019-2021 | |
| Axsome Therapeutics, INC. | $149.53 | 2023 | Auvelity |
| Phathom Pharmaceuticals, INC. | $143.32 | 2024 | Voquezna |
| Medtronic, INC. | $142.09 | 2021-2024 | Intellis Adaptivestim |
| Nalu Medical, INC. | $139.45 | 2024 | Nalu Neurostimulation System |
| Vertiflex, INC. | $131.92 | 2019 | |
| Ebi, LLC | $126.06 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Teleflex LLC | $126.04 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $125.80 | 2020 | |
| Saluda Medical Americas, INC. | $122.21 | 2023 | Evoke Scs |
| Collegium Pharmaceutical, INC. | $117.36 | 2019-2023 | Xtampza |
| Arbor Pharmaceuticals, INC. | $114.16 | 2019-2021 | |
| Lundbeck LLC | $94.35 | 2025 | Vyepti |
| Scilex Pharmaceuticals INC. | $76.00 | 2019-2024 | Ztlido |
| Azurity Pharmaceuticals, INC. | $73.19 | 2023-2025 | Horizant, Horizant |
| Almatica Pharma LLC | $71.69 | 2021-2022 | |
| Orexo US, INC. | $67.70 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $53.72 | 2019-2020 | |
| Abbott Laboratories | $53.50 | 2021 | |
| Shionogi INC | $52.70 | 2019 | |
| Curonix LLC | $46.94 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Galderma Laboratories, L.P. | $44.38 | 2023-2024 | Dysport |
| Daiichi Sankyo INC. | $43.07 | 2019 | |
| Royal Biologics, INC. | $35.63 | 2020 | |
| Redhill Biopharma INC. | $34.97 | 2020-2021 | |
| Lilly USA, LLC | $27.49 | 2025 | Zepbound, Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $24.60 | 2022 | |
| Stryker Corporation | $24.53 | 2021 | |
| Si-Bone, INC. | $24.36 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $23.24 | 2023 | |
| Grt US Holding, INC. | $20.90 | 2021 | |
| Hikma Pharmaceuticals USA | $18.77 | 2022 | |
| Pacira Therapeutics, INC. | $17.52 | 2021 | |
| Assertio Therapeutics, INC. | $17.11 | 2019 | |
| Baudax Bio INC. | $14.61 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.78 | 2019 | |
| Sentynl Therapeutics, INC. | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randa Jaafar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.